Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
We work very hard (sometimes biting off more than we can chew as a company) but it is a very rewarding place to work.
Was gefällt dir am besten am Führungsteam?
Honesty, passion, determination, innovative, hard-working
Was ist das Beste an Ihrem Vergütungspaket?
stock incentives, salary, bonus, benefits
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
results-oriented, company keeps patients-first, innovative-thinking,
Was macht Sie bei der Arbeit am glücklichsten?
Seeing the impact we are having on patients' lives
Other Employee Reviews for Karyopharm Therapeutics
×